FULC
Fulcrum Therapeutics, Inc.
$3.72
-0.12 (-3.13%)
At close · Jul 6
Market Cap
$247.88M
Shares
66,633,321
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-04-27 | Fulcrum Therapeutics First Quarter 2026 Earnings Call | Earnings call |
| 2026-03-10 | Leerink Partners Global Healthcare Conference | Conference |
| 2026-02-24 | Pociredir PIONEER Study: 20 mg Cohort Data Update | Event |
| 2026-01-14 | 44th Annual J.P. Morgan Healthcare Conference | Conference |
| 2025-12-07 | Virtual Investor Event to Review New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease | Event |
| 2025-07-29 | Pociredir Pioneer Study: 12 mg Cohort Data Release | Event |
Source: https://ir.fulcrumtx.com/